drug interaction(s) of phosphodiesterase-5-inhibitor with nitrates

From Aaushi
Jump to navigation Jump to search

Drug interactions

More general terms

References

  1. 1.0 1.1 1.2 Holt A et al. Adverse events associated with coprescription of phosphodiesterase type 5 inhibitors and oral organic nitrates in male patients with ischemic heart disease: A case-crossover study. Ann Intern Med 2022 Apr 19; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35436155 https://www.acpjournals.org/doi/10.7326/M21-3445
  2. 2.0 2.1 Trolle Lagerros Y et al. Risk of death in patients with coronary artery disease taking nitrates and phosphodiesterase-5 inhibitors. J Am Coll Cardiol 2024 Jan 23; 83:417. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38233015 Free article https://www.sciencedirect.com/science/article/pii/S0735109723080749